TipRanks
Go Ultimate55% OFF

Z Squared (ZSQR) AI Stock Analysis

ZSQR

Z Squared

(NASDAQ:ZSQR)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Negative Factors

Z Squared (ZSQR) vs. SPDR S&P 500 ETF (SPY)

-100%-75%-50%-25%0%25%50%ZSQR-75.66%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$191.86M
Dividend Yield
―
Average Volume (3M)
407.93K
Price to Earnings (P/E)
-2.0
Beta (1Y)
0.72
Revenue Growth
961.16%
EPS Growth
58.59%
Country
US
Employees
6
Sector
Technology
Sector Strength
61
Industry
Software - Services

Z Squared Business Overview & Revenue Model

Company Description

Z Squared Inc. operates as an integrated computing infrastructure company, deploying and managing advanced computing equipment across its facilities in North Carolina, South Carolina, and Iowa. The firm diligently oversees and optimizes its extensive...

Z Squared Risk Analysis

Z Squared disclosed 26 risk factors in its most recent earnings report. Z Squared reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.BSG Series CM, LLC, the entity from which we acquired our entire mining fleet, was our controlling stockholder immediately after the business combination and is a named defendant in SEC enforcement proceedings.Q2, 2026
2.Future sales of substantial amounts of our common stock, including shares distributed by BSG to its former members, could adversely affect the market price.Q2, 2026
3.Holders of the Company's common stock have experienced and may continue to experience significant dilution.Q2, 2026

Z Squared Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

ZSQR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
PRLDPRLD53Neutral$309.64M-4.91-75.35%―220.34%55.73%
RLMDRLMD48Neutral$381.88M-3.89-47.52%――57.98%
HOWLHOWL47Neutral$47.92M-1.34-166.98%――55.37%
ABVCABVC43Neutral$26.69M-3.39-71.47%―-100.00%-55.90%

* Technology Sector Average

Performance Comparison

0%100%200%ZSQRRLMDABVCPRLDHOWLESLADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
ZSQR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ZSQRZ Squared Inc.3.59-11.84-76.73%
RLMDRelmada Therapeutics Inc3.581.3862.73%
ABVCABVC BioPharma, Inc.1.00-1.96-66.22%
PRLDPrelude Therapeutics, Inc.3.88-0.10-2.51%
HOWLWerewolf Therapeutics, Inc.0.99-0.32-24.73%
ESLAEstrella Immunopharma, Inc.0.64-2.41-79.05%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.